Financial Health Assessment: SWEAT GUARD LTD

1. Financial Health Score: C+

Explanation: The patient has a strong constitution built over years of growth, but is presenting acute symptoms that require immediate attention. While the company's net asset position remains healthy at £403k and it can comfortably meet short-term obligations, the dramatic 88% collapse in cash reserves and heavy reliance on debtors (81% of current assets) are significant warning signs. The recent decline in net assets and multiple director departures add to concerns about the current trajectory.

2. Key Vital Signs

Interpretation:

• Cash Hemorrhage: The most alarming vital sign. Cash has drained from £245k to just £29k – equivalent to a patient losing 88% of their blood volume. This demands urgent investigation into where the money has gone.

• Debtors Swelling: Money owed to the company has nearly doubled to £358k. This is like poor circulation – revenue may be being generated but not converting to cash. This could indicate aggressive credit sales, related party balances, or collection difficulties.

• Net Assets Decline: The £92k drop in net worth suggests the company operated at a loss during 2024, or there were significant distributions/adjustments.

• Current Ratio: While still robust at nearly 10x, the sharp decline from 16.7x indicates the liquidity cushion is eroding.

3. Diagnosis

Primary Condition: Acute Cash Flow Distress with Debtors Concentration Risk

The financial data reveals a business that has undergone a fundamental shift in its working capital structure. The dramatic shift from cash-rich to cash-poor, combined with the near-doubling of debtors, suggests one or more of the following:

1. Large Credit Sales: The company may have extended significant credit to customers, potentially including related parties. With debtors representing 81% of current assets, this is an unhealthy concentration – like having 81% of your weight on one leg.

2. Possible Related Party Transactions: The PSC register shows Covestus Limited and Mr David Andrew Tebb both with 75%+ ownership declarations. The significant debtor balance could include inter-company balances requiring investigation.

3. Profitability Concerns: The £92k decline in net assets (absent any dividend declarations) suggests the business may have traded at a loss during 2024, burning through accumulated reserves.

4. Director Departures: Two directors resigned in December 2025 and one in September 2026. While timing aligns with normal board changes, multiple departures alongside financial deterioration can be a symptom of underlying strategic disagreements or concerns.

Secondary Condition: Slowing Growth Momentum

The 10-year trajectory shows remarkable growth from £1,728 net assets in 2015 to nearly £500k by 2023. However, 2024 represents a reversal, suggesting the business may be facing market headwinds, increased competition, or operational challenges in the hyperhidrosis treatment market.

4. Recommendations

Immediate (Within 30 Days)

• Cash Flow Emergency Plan: Conduct an urgent cash flow forecast. With only £29k in cash and £44.6k in current liabilities, the company has limited runway if debtors don't convert to cash promptly.
• Debtors Review: Immediately review the £358k debtor balance. Identify aged debtors, assess collectibility, and initiate collection procedures for overdue amounts. Determine how much relates to related parties.
• Creditor Payment Schedule: Map out when the £44.6k in current liabilities falls due to ensure payment capability.

Short-term (1-3 Months)

• Working Capital Management: Implement stricter credit control policies. The shift from cash sales to credit sales needs to be reversed or better managed.
• Debtor Days Analysis: Calculate how long customers are taking to pay. If debtor days are extending, this indicates the company is effectively financing its customers' purchases.
• Review Related Party Balances: Clarify and document any amounts owed by Covestus Limited or connected parties.

Medium-term (3-12 Months)

• Profitability Restoration: Understand what drove the net asset decline. If trading losses, identify whether these are temporary (investment phase) or structural (margin erosion).
• Cash Reserve Target: Aim to rebuild cash reserves to a minimum of 3 months of operating expenses as a buffer.
• Diversification of Current Assets: Reduce the unhealthy concentration in debtors. A healthier balance would see debtors representing no more than 40-50% of current assets.

Ongoing Monitoring

• Monthly Cash Flow Reporting: Given the severity of the cash decline, monthly monitoring is essential.
• Debtor Aging Reports: Weekly review of aged debtors until the position stabilises.
• Director Stability: Ensure remaining board members are aligned on strategy during this period of financial stress.

Prognosis

Cautiously Guarded: The company has a solid balance sheet foundation with £403k in net assets and no long-term debt, providing resilience against immediate failure. However, the dramatic cash deterioration and heavy debtor concentration create significant vulnerability. If debtors convert to cash as expected, the patient can recover quickly. If significant debtors prove uncollectible, the condition could deteriorate rapidly. The next 6-12 months are critical – the business needs to demonstrate it can convert its debtor book back into cash and return to profitability. The recent director departures add uncertainty to the strategic direction during this recovery period.